Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gerald T. Proehl currently holds 30,000 shares of Dermata Therapeutics, Inc. (DRMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gerald T. Proehl has been a net seller of DRMA stock. They have purchased $577.9K and sold $12.1M worth of shares.
Gerald T. Proehl's most recent insider trade was on Jan 9, 2026, when they sold 3,000 shares at $0.00 per share.
Gerald T. Proehl serves as Executive at Dermata Therapeutics, Inc. (DRMA). They have executed 165 insider transactions totaling $12.6M over their tenure at the company.
Gerald T. Proehl holds the position of Executive at Dermata Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gerald T. Proehl has shown a selling trading pattern, with $577.9K in total purchases and $12.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gerald T. Proehl was on Jan 2, 2014, when they sold $9.5M worth of SNTS shares. This transaction involved 298,033 shares at $32.00 per share.
Gerald T. Proehl currently owns 30,000 shares of Dermata Therapeutics, Inc. (DRMA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gerald T. Proehl's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gerald T. Proehl has 165 Form 4 filings on record as an insider at Dermata Therapeutics, Inc..
Set alerts for Gerald T. Proehl and 40,000+ other insiders.